Tag: Steroid free treatment

Opzelura (ruxolitinib) is the first and only topical Janus kinase (JAK) inhibitor approved by the FDA for repigmentation in nonsegmental vitiligo, as well as for treating mild-to-moderate atopic dermatitis. Its function is to modulate the immune system's overactive signaling pathways that contribute to these chronic skin conditions.

An estimated 38 million adults in the USA are affected by dry eye disease [1.4.6]. For those seeking relief, a common question arises about newer treatments: **Is Tyrvaya a steroid?** The answer is no; it belongs to a completely different class of medications [1.2.1, 1.2.2].